Cargando…

Update of the S2k guideline on the management of IgE-mediated food allergies

Not available.

Detalles Bibliográficos
Autores principales:	Worm, Margitta, Reese, Imke, Ballmer-Weber, Barbara, Beyer, Kirsten, Bischoff, Stephan C. , Bohle, Barbara, Brockow, Knut, Claßen, Martin, Fischer, Peter J., Hamelmann, Eckard, Jappe, Uta, Kleine-Tebbe, Jörg, Klimek, Ludger, Koletzko, Berthold, Lange, Lars, Lau, Susanne, Lepp, Ute, Mahler, Vera , Nemat, Katja , Raithel, Martin, Saloga, Joachim, Schäfer, Christiane, Schnadt, Sabine, Schreiber, Jens, Szépfalusi, Zsolt, Treudler, Regina, Wagenmann, Martin, Werfel, Thomas, Zuberbier, Torsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dustri-Verlag Dr. Karl Feistle 2021
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276640/ https://www.ncbi.nlm.nih.gov/pubmed/34263109 http://dx.doi.org/10.5414/ALX02257E

Ejemplares similares

Guidelines on the management of IgE-mediated food allergies: S2k-Guidelines of the German Society for Allergology and Clinical Immunology (DGAKI) in collaboration with the German Medical Association of Allergologists (AeDA), the German Professional Association of Pediatricians (BVKJ), the German Allergy and Asthma Association (DAAB), German Dermatological Society (DDG), the German Society for Nutrition (DGE), the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS), the German Society for Oto-Rhino-Laryngology, Head and Neck Surgery, the German Society for Pediatric and Adolescent Medicine (DGKJ), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Society for Pneumology (DGP), the German Society for Pediatric Gastroenterology and Nutrition (GPGE), German Contact Allergy Group (DKG), the Austrian Society for Allergology and Immunology (Æ-GAI), German Professional Association of Nutritional Sciences (VDOE) and the Association of the Scientific Medical Societies Germany (AWMF)
por: Worm, Margitta, et al.
Publicado: (2015)

Food allergies resulting from immunological cross-reactivity with inhalant allergens: Guidelines from the German Society for Allergology and Clinical Immunology (DGAKI), the German Dermatology Society (DDG), the Association of German Allergologists (AeDA) and the Society for Pediatric Allergology and Environmental Medicine (GPA)
por: Worm, Margitta, et al.
Publicado: (2014)

Guideline on management of suspected adverse reactions to ingested histamine: Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergology and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA) as well as the Swiss Society for Allergology and Immunology (SGAI) and the Austrian Society for Allergology and Immunology (ÖGAI)
por: Reese, Imke, et al.
Publicado: (2021)

German guideline for the management of adverse reactions to ingested histamine: Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Association of Allergologists (AeDA), and the Swiss Society for Allergology and Immunology (SGAI)
por: Reese, Imke, et al.
Publicado: (2017)

Severe allergic reactions to the COVID-19 vaccine – statement and practical consequences
por: Kleine-Tebbe, Jörg, et al.
Publicado: (2021)

Allergen and allergy risk assessment, allergen management, and gaps in the European Food Information Regulation (FIR): Are allergic consumers adequately protected by current statutory food safety and labelling regulations?
por: Reese, Imke, et al.
Publicado: (2015)

Non-celiac gluten/wheat sensitivity (NCGS)—a currently undefined disorder without validated diagnostic criteria and of unknown prevalence: Position statement of the task force on food allergy of the German Society of Allergology and Clinical Immunology (DGAKI)
por: Reese, Imke, et al.
Publicado: (2018)

COVID-19 vaccination of patients with allergies and type-2 inflammation with concurrent antibody therapy (biologicals) – A Position Paper of the German Society of Allergology and Clinical Immunology (DGAKI) and the German Society for Applied Allergology (AeDA)
por: Pfaar, Oliver, et al.
Publicado: (2021)

COVID-19 vaccination and allergen immunotherapy (AIT) – A position paper of the German Society for Applied Allergology (AeDA) and the German Society for Allergology and Clinical Immunology (DGAKI)
por: Klimek, Ludger, et al.
Publicado: (2021)

COVID-19-Impfungen von Patienten mit Allergien und Typ2-entzündlichen Erkrankungen bei gleichzeitiger Antikörpertherapie (Biologika): Ein Positionspapier der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI) und dem Ärzteverband Deutscher Allergologen (AeDA)
por: Pfaar, Oliver, et al.
Publicado: (2021)

Allergen immunotherapy during the COVID‐19 pandemic—A survey of the German Society for Allergy and Clinical Immunology
por: Pfaar, Oliver, et al.
Publicado: (2022)

Vegan diets from an allergy point of view – Position paper of the DGAKI working group on food allergy
por: Reese, Imke, et al.
Publicado: (2023)

Management von Anaphylaxie-gefährdeten Patienten während der Covid-19-Pandemie: Ein Positionspapier des Ärzteverbandes Deutscher Allergologen (AeDA)A, der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI)B, der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C und des Deutschen Allergie- und Asthmabundes (DAAB)D
por: Klimek, Ludger, et al.
Publicado: (2020)

Biologika und Covid-19
por: Buhl, Roland, et al.
Publicado: (2020)

Standardization of double blind placebo controlled food challenge with soy within a multicentre trial
por: Treudler, R., et al.
Publicado: (2016)

Guideline on allergen immunotherapy in IgE-mediated allergic diseases: S2K Guideline of the German Society of Allergology and Clinical Immunology (DGAKI), Society of Pediatric Allergology and Environmental Medicine (GPA), Medical Association of German Allergologists (AeDA), Austrian Society of Allergology and Immunology (ÖGAI), Swiss Society for Allergology and Immunology (SSAI), German Dermatological Society (DDG), German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), German Society of Pediatrics and Adolescent Medicine (DGKJ), Society of Pediatric Pulmonology (GPP), German Respiratory Society (DGP), German Professional Association of Otolaryngologists (BVHNO), German Association of Paediatric and Adolescent Care Specialists (BVKJ), Federal Association of Pneumologists, Sleep and Respiratory Physicians (BdP), Professional Association of German Dermatologists (BVDD)
por: Pfaar, Oliver, et al.
Publicado: (2022)

Biologics for atopic diseases: Indication, side effect management, and new developments
por: Jappe, Uta, et al.
Publicado: (2021)

Molecular allergy diagnostic tests: development and relevance in clinical practice
por: Kleine-Tebbe, J., et al.
Publicado: (2017)

Practical recommendations for the allergological risk assessment of the COVID-19 vaccination – a harmonized statement of allergy centers in Germany
por: Worm, Margitta, et al.
Publicado: (2021)

Precision medicine reaching out to the patients in allergology – a German-Japanese workshop report
por: Pfaar, Oliver, et al.
Publicado: (2021)

Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA)
por: Klimek, Ludger, et al.
Publicado: (2021)

S3 Guideline Allergy Prevention*
por: Kopp, Matthias V., et al.
Publicado: (2022)

Allergene - Auslöser der verschiedenen Allergievarianten
por: Kleine-Tebbe, Jörg, et al.
Publicado: (2022)

Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI
por: Klimek, Ludger, et al.
Publicado: (2021)

Schwere allergische Reaktionen nach COVID-19-Impfung mit dem Impfstoff von Pfizer/BioNTech in Großbritannien und USA: Stellungnahme der deutschen allergologischen Gesellschaften AeDA (Ärzteverband Deutscher Allergologen), DGAKI (Deutsche Gesellschaft für Allergologie und klinische Immunologie) und GPA (Gesellschaft für Pädiatrische Allergologie und Umweltmedizin)
por: Klimek, Ludger, et al.
Publicado: (2021)

Glukokortikoide und Covid-19
por: Klimek, Ludger, et al.
Publicado: (2020)

S3-Guideline on allergy prevention: 2014 update: Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Society for Pediatric and Adolescent Medicine (DGKJ)
por: Schäfer, Torsten, et al.
Publicado: (2014)

Evidence vs. efficacy in allergen-specific immunotherapy: Considerations using the example of tradable products in Germany
por: Brehler, Randolf, et al.
Publicado: (2016)

Analysis of the IgE epitope profile of soybean allergen Gly m 4
por: Husslik, Felix, et al.
Publicado: (2014)

Immuntherapien von Allergien: Aktueller Stand
por: Mahler, Vera, et al.
Publicado: (2020)

Healthcare provision for insect venom allergy patients during the COVID-19 pandemic
por: Worm, Margitta, et al.
Publicado: (2020)

Versorgungssituation von Insektengiftallergikern während der COVID-19-Pandemie
por: Worm, Margitta, et al.
Publicado: (2020)

Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium
por: Hamelmann, Eckard
Publicado: (2018)

Long-acting muscarinic antagonists for the treatment of asthma in children—a new kid in town
por: Hamelmann, Eckard
Publicado: (2018)

Corrigendum to “Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium”
por: Hamelmann, Eckard
Publicado: (2019)

Leitlinie zu Akuttherapie und Management der Anaphylaxie - Update 2021: S2k-Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI), des Ärzteverbands Deutscher Allergologen (AeDA), der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA), der Deutschen Akademie für Allergologie und Umweltmedizin (DAAU), des Berufsverbands der Kinder- und Jugendärzte (BVKJ), der Gesellschaft für Neonatologie und Pädiatrische Intensivmedizin (GNPI), der Deutschen Dermatologischen Gesellschaft (DDG), der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI), der Schweizerischen Gesellschaft für Allergologie und Immunologie (SGAI), der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin (DGAI), der Deutschen Gesellschaft für Pharmakologie (DGP), der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP), der Patientenorganisation Deutscher Allergie- und Asthmabund (DAAB) und der Arbeitsgemeinschaft Anaphylaxie - Training und Edukation (AGATE)
por: Ring, Johannes, et al.
Publicado: (2021)

Randomized immunotherapy trial in dual‐allergic patients using “active allergen placebo” as control
por: Wagenmann, Martin, et al.
Publicado: (2019)

Clinical trials in allergen immunotherapy: current concepts and future needs
por: Pfaar, O., et al.
Publicado: (2018)

Implementation of Anaphylaxis Management Guidelines: A Register-Based Study
por: Grabenhenrich, Linus, et al.
Publicado: (2012)

Messages for patients and relatives from the 2021 update of the guideline on acute therapy and management of anaphylaxis
por: Ring, Johannes, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_03bdavpgjmtji7r90jg08jit33